Merck Presents New Phase 3 Data for Investigationa...
Category : Clinical Trial Update 16 October 2025Merck (known as MSD outside the U.S. and Canada) presented additional results from two Phase 3 clini...
Clinical Trial Update
Clover Biopharmaceuticals Reports Positive Early D...
Category : Clinical Trial Update 16 October 2025Clover Biopharmaceuticals, Ltd., a global commercial-stage biotechnology company focused on developi...
Boehringer Ingelheim and Click Therapeutics Report...
Category : Clinical Trial Update 16 October 2025Boehringer Ingelheim and Click Therapeutics presented data from the pivotal phase III CONVOKE study...
CalciMedica and Telperian Collaborate to Apply AI...
Category : Clinical Trial Update 16 October 2025CalciMedica Inc., a clinical-stage biopharmaceutical company developing CRAC channel inhibition ther...
Ascletis Pharma Selects ASC35 as Once-Monthly GLP-...
Category : Clinical Trial Update 13 October 2025Ascletis Pharma Inc. (HKEX: 1672) has unveiled ASC35, a next-generation GLP-1/GIP dual peptide agoni...
Latest Newsletter Post
-
CalciMedica and Telperian Collabora..
16 October 2025
-
Boehringer Ingelheim and Click Ther..
16 October 2025
-
Clover Biopharmaceuticals Reports P..
16 October 2025
-
Merck Presents New Phase 3 Data for..
16 October 2025
-
Quotient Sciences and Biorasi Partn..
15 October 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com